ATHENA MAMMOGRAPHIC TECHNOLOGY

Information

  • Research Project
  • 6016552
  • ApplicationId
    6016552
  • Core Project Number
    R43CA083453
  • Full Project Number
    1R43CA083453-01
  • Serial Number
    83453
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/30/1999 - 26 years ago
  • Project End Date
    3/31/2001 - 24 years ago
  • Program Officer Name
    TORRES-ANJEL, MANUEL J.
  • Budget Start Date
    7/30/1999 - 26 years ago
  • Budget End Date
    3/31/2001 - 24 years ago
  • Fiscal Year
    1999
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/30/1999 - 26 years ago
Organizations

ATHENA MAMMOGRAPHIC TECHNOLOGY

The proposed SBIR Phase I study will research and prototype a computer- based mammographic visualization environment named the Athena Mammographic Technology (AMY). AMY will provide radiologists with superior images that enhance mammographic sensitivity and specificity, leading to a more accurate detection and classification of lesions. This in turn will result in a more accurate diagnostic conclusion about the subject, amplify productivity, and potentially reduce health care delivery costs. The study will focus on developing the AMY system under the guidance of practicing radiologists, and performing an evaluation based on a receiver operating characteristic (ROC) analysis. Athena will develop wavelet-based methods of selectively enhancing specific malignant and important non-malignant features, and devise an effective means of fusing together the salient information to provide a superior image. The result will be an innovative system providing higher quality globally and locally enhanced mammographic images that can be conveniently manipulated by the radiologist using simple, intuitive commands. The validity of the AMY paradigm will be established in Phase I through the comprehensive test and evaluation of a standard mammographic database by a panel of mammographers. Quantitative ROC studies will provide insights into the value of mammographic images enhanced by the AMY system. PROPOSED COMMERCIAL APPLICATIONS: The Phase I study will produce the validated definition of a system that will be comprehensively tested in Phase II. Once proven, AMY will be commercially developed in a strategic partnership with an original equipment manufacturer (OEM) of digital mammography equipment. The technology transfer process is simplified by the fact that AMY is essentially a software enhancement to an OEM's existing digital mammography systems.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
  • Organization Name
    ATHENA GROUP, INC.
  • Organization Department
  • Organization DUNS
    362312290
  • Organization City
    GAINESVILLE
  • Organization State
    FL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    326015289
  • Organization District
    UNITED STATES